Arlington Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-422
| Closed | -$28.4K | – | 77 |
|
|
2023
Q4 | $28.4K | Buy |
+422
| New | +$28.4K | 0.01% | 166 |
|
|
2023
Q3 | – | Sell |
-856
| Closed | -$61.3K | – | 368 |
|
|
2023
Q2 | $61.3K | Buy |
856
+351
| +70% | +$25.1K | 0.01% | 287 |
|
|
2023
Q1 | $35.1K | Buy |
505
+83
| +20% | +$5.76K | 0.01% | 291 |
|
|
2022
Q4 | $28.6K | Hold |
422
| – | – | ﹤0.01% | 271 |
|
|
2022
Q3 | $23K | Hold |
422
| – | – | 0.01% | 249 |
|
|
2022
Q2 | $28K | Hold |
422
| – | – | 0.01% | 290 |
|
|
2022
Q1 | $28K | Hold |
422
| – | – | 0.01% | 294 |
|
|
2021
Q4 | $25K | Buy |
+422
| New | +$25K | 0.01% | 347 |
|